×

Kite Pharma to Present at the 2015 Barclays Global Healthcare Conference

SANTA MONICA, Calif., March 6, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today announced that David Chang, M.D., Ph.D., Kite's Executive Vice President, Research and Development, and Chief Medical Officer, will present a company overview at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel. The presentation will take place on Tuesday March 10, 2015, at 9:30 a.m. EDT.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT™ designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.

CONTACT: Kite Contacts: Cynthia M. Butitta Chief Financial Officer and Chief Operating Officer (310) 824-9999 For Media: Justin Jackson For Investor Inquiries: Nancy Yu Burns McClellan (212) 213-0006 jjackson@burnsmc.com nyu@burnsmc.com

Source:Kite Pharma, Inc.